Highly skilled drug developer with over ten years in the pharmaceutical industry. Broad global drug development leadership experience with strong strategic skills and experience prioritizing and contributing to large portfolios and technical platforms.
Skilled in ophthalmic drug development for retinal diseases of small molecules, biologics, medical devices and ocular drug delivery systems from lead optimization through registration. Toxicologist, adept at planning, executing, and interpreting non-clinical toxicology studies to support FIH and ongoing clinical trials, as well as preparation of global regulatory submissions and global Health Authorities interactions. Strong scientific background in ocular toxicology, as well as neuro drug development therapeutic areas.